EuroAPI Logo

EuroAPI

Develops and manufactures APIs and provides CDMO services for complex molecules.

EAPI | PA

Overview

Corporate Details

ISIN(s):
FR0014008VX5 (+2 more)
LEI:
9695002FT7GGI3CKKJ14
Country:
France
Address:
15 RUE TRAVERSIERE, 75012 PARIS

Description

EuroAPI is a developer and manufacturer of Active Pharmaceutical Ingredients (APIs), focusing on small and complex molecules. The company's business is centered on two main activities: offering API solutions from its large portfolio and providing Contract Development and Manufacturing Organization (CDMO) services. The product portfolio contains over 200 ingredients, with expertise in categories such as opiates and controlled substances, prostaglandins, corticoids, hormones, anti-infectives, and Vitamin B12. As a CDMO, EuroAPI provides services for complex chemistry, including small molecule synthesis, microbial fermentation, particle engineering (micronization and spray drying), and the development of lipids and tides like oligonucleotides, serving a global customer base.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-16 17:47
Market update
English 544.4 KB
2025-12-16 17:47
Information marché
French 542.1 KB
2025-12-10 17:45
Tristan Imbert coopté Administrateur Indépendant
French 545.9 KB
2025-12-10 17:45
Tristan Imbert co-opted as Independent Director
English 546.4 KB
2025-10-23 17:45
Avec Med4Cure, EUROAPI accélère l’innovation pharmaceutique au service de la so…
French 750.3 KB
2025-10-23 17:45
With Med4Cure, EUROAPI accelerates pharmaceutical innovation at the service of …
English 748.2 KB
2025-09-30 17:45
Evolution de la composition du Conseil d’administration
French 535.7 KB
2025-09-30 17:45
Change in Board’s Composition
English 537.6 KB
2025-09-18 07:00
Climat : la Science Based Targets initiative (SBTi) valide les objectifs à cour…
French 536.3 KB
2025-09-18 07:00
Science Based Targets initiative (SBTi) validates EUROAPI’s near-term climate t…
English 519.3 KB
2025-08-11 14:50
Franchissement de seuil
French 82.0 KB
2025-07-31 18:30
Mise à disposition du Rapport financier semestriel 2025
French 444.9 KB
2025-07-31 18:30
Availability of 2025 Half-Year Financial Report
English 442.4 KB
2025-07-31 00:00
Rapport financier semestriel 2025
French 14.1 MB
2025-07-29 18:42
Résultats du premier semestre 2025
French 839.8 KB

Automate Your Workflow. Get a real-time feed of all EuroAPI filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for EuroAPI

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for EuroAPI via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Bone Biologics Corp Logo
Develops a protein-based bone graft substitute for spinal fusion procedures.
United States of America
BBLG
Bonyf N.V. Logo
Develops medical devices for oral, dental, orthodontic, and dermatological care.
Belgium
MLBON
Boryung Corporation Logo
A healthcare company developing pharmaceuticals and investing in health sector innovation.
South Korea
003850
Bosnalijek d.d. Sarajevo Logo
Develops, manufactures, and exports a wide range of pharmaceutical products.
Bosnia and Herzegovina
BSNL
Boule Diagnostics Logo
Provider of hematology systems for decentralized human and veterinary markets.
Sweden
BOUL
Boundless Bio, Inc. Logo
Clinical-stage oncology company targeting ecDNA in oncogene amplified cancers.
United States of America
BOLD
BridgeBio Oncology Therapeutics, Inc. Logo
Clinical-stage biopharma developing inhibitors for genetically driven cancers.
United States of America
BBOT
BridgeBio Pharma, Inc. Logo
Develops transformative medicines for genetic diseases and cancers.
United States of America
BBIO
BRIGHT MINDS BIOSCIENCES INC. Logo
Develops selective serotonin agonists for neurological and psychiatric disorders.
United States of America
DRUG
A clinical-stage biopharma company developing cancer immunotherapies and cell therapies.
Japan
4594

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.